Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer screening: current trends and future implications.

P J Littrup1, F Lee, C Mettlin

  • 1Department of Radiology, St. Joseph Mercy Hospital, Ann Arbor, Michigan.

CA: a Cancer Journal for Clinicians
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vertical heterostructure of graphite-MoS<sub>2</sub> for gas sensing.

Nanoscale horizons·2024
Same author

Performance of the new biological small- and wide-angle X-ray scattering beamline 13A at the Taiwan Photon Source.

Journal of applied crystallography·2022
Same author

2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Correlation between biochemical features and outcomes of preoperative imaging (SPECT-CT and Ultrasound) in primary hyperparathyroidism.

Acta endocrinologica (Bucharest, Romania : 2005)·2022
Same author

Consumer trait responses track change in resource supply along replicated thermal gradients.

Proceedings. Biological sciences·2021
Same author

Development and internal validation of clinical prediction models for outcomes of complicated intra-abdominal infection.

The British journal of surgery·2021

Screening for prostate cancer is complex. Combining digital rectal exam (DRE), transrectal ultrasound (TRUS), and prostate-specific antigen (PSA) tests improves early detection and cost-effectiveness, though mortality benefits require further study.

Area of Science:

  • Urology
  • Oncology
  • Diagnostic Imaging

Background:

  • Prostate cancer screening presents a clinical challenge with inconclusive evidence on mortality reduction.
  • Current screening methods like digital rectal exam (DRE), transrectal ultrasound (TRUS), and prostate-specific antigen (PSA) have limitations in subjectivity and specificity.

Purpose of the Study:

  • To evaluate the optimal combination of DRE, TRUS, and PSA for cost-effective prostate cancer screening.
  • To refine decision-making criteria for PSA levels and TRUS-guided biopsies.

Main Methods:

  • Analysis of combined predictive values of DRE, TRUS, and PSA.
  • Establishing a monoclonal PSA decision level of no more than 4.0 ng/ml.
  • Utilizing TRUS gland volume data to modify PSA decision levels ('predicted' PSA).

Related Experiment Videos

Main Results:

  • Combined screening identifies high-risk individuals and those for whom frequent screening is not cost-effective.
  • A PSA threshold of 4.0 ng/ml is recommended, as higher levels correlate with advanced disease.
  • Combining PSA and DRE offers cost-effective early detection for men with PSA < 4.0 ng/ml.
  • TRUS is best reserved for patients with elevated PSA or abnormal DRE findings.

Conclusions:

  • Optimized screening strategies using combined DRE, TRUS, and PSA can improve the selection of patients for early detection of localized prostate cancer.
  • Further randomized trials are needed to definitively demonstrate a decrease in prostate cancer mortality attributable to screening.